The Depiction of Hypertension in Heart Imaging Examinations: An Up-to-Date Review of the Evidence

References

• Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. 2023. Cause of Death (1999–2019).
   Google Scholar
• Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018 Key findings Data from the National Health and Nutrition Examination Survey. 2017. Available from: https://www.cdc.gov/nchs/products/index.htm. Accessed November 23, 2023.
   Google Scholar
• Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980.
   PubMed Web of Science ®Google Scholar
• Tackling G, Borhade MB. Hypertensive Heart Disease. StatPearls publishing; 2023.
   Google Scholar
• Hoey E, Pakala V, Teoh J, Simpson H. The Role of Imaging in Hypertensive Heart Disease. Int J Angiol. 2014;23(02):085–92. doi:10.1055/s-0034-1370885
   PubMedGoogle Scholar
• Drazner MH. The Progression of Hypertensive Heart Disease. Circulation. 2011;123(3):327–334. doi:10.1161/CIRCULATIONAHA.108.845792
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561–1566. doi:10.1056/NEJM199005313222203
   PubMed Web of Science ®Google Scholar
• Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Investigation. 2007;117(3):568–575. doi:10.1172/JCI31044
   PubMed Web of Science ®Google Scholar
• Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55(4):613–618. doi:10.1161/01.CIR.55.4.613
   PubMed Web of Science ®Google Scholar
• Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New Gender-Specific Partition Values for ECG Criteria of Left Ventricular Hypertrophy. Hypertension. 2004;44(2):175–179. doi:10.1161/01.HYP.0000135249.66192.30
   PubMed Web of Science ®Google Scholar
• Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19(7):1550–1558. doi:10.1016/0735-1097(92)90617-V
   PubMed Web of Science ®Google Scholar
• Ross, Jr JJ. On Variations in the Cardiac Hypertrophic Response to Pressure Overload. Circulation. 1997;95(6):1349–1351. doi:10.1161/01.CIR.95.6.1349
   PubMed Web of Science ®Google Scholar
• Vasan RS, Song RJ, Xanthakis V, et al. Hypertension-Mediated Organ Damage: prevalence, Correlates, and Prognosis in the Community. Hypertension. 2022;79(3):505–515. doi:10.1161/HYPERTENSIONAHA.121.18502
   PubMed Web of Science ®Google Scholar
• Wang X, Hao G, Chen L, et al. Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012–2015. J Hum Hypertens. 2022;36(12):1092–1098. doi:10.1038/s41371-021-00635-z
   PubMed Web of Science ®Google Scholar
• Cai A, Liu L, Zhou D, Tang S, Zhou Y, Feng Y. Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations. J Hypertens. 2022;40(6):1170–1178. doi:10.1097/HJH.0000000000003127
   PubMed Web of Science ®Google Scholar
• Shin S, Jang J, Baek Y, et al. Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients. Singapore Med J. 2019;60(8):427–431. doi:10.11622/smedj.2019030
   PubMed Web of Science ®Google Scholar
• Kai XF, Li P, Ying HZ, Jing L, Hua S, Sha ZL. Patients with Dipper and Nondipper High-Normal Blood Pressure Were Associated with Left Ventricular Mass. Int J Hypertens. 2021;2021:1–5. doi:10.1155/2021/6946418
   Web of Science ®Google Scholar
• Ahmed SN, Jhaj R, Sadasivam B, Joshi R. Reversal of hypertensive heart disease: a multiple linear regression model. Discoveries. 2021;9(4):e138. doi:10.15190/d.2021.17
   Google Scholar
• Devereux RB. Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension. JAMA. 2004;292(19):2350. doi:10.1001/jama.292.19.2350
   PubMed Web of Science ®Google Scholar
• Kannel WB. Left Ventricular Hypertrophy by Electrocardiogram. Ann Intern Med. 1969;71(1):89. doi:10.7326/0003-4819-71-1-89
   PubMed Web of Science ®Google Scholar
• Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007;335(7622):711. doi:10.1136/bmj.39276.636354.AE
   PubMed Web of Science ®Google Scholar
• Sayin BY, Oto A. Left Ventricular Hypertrophy: etiology-Based Therapeutic Options. Cardiol Ther. 2022;11(2):203–230. doi:10.1007/s40119-022-00260-y
   PubMed Web of Science ®Google Scholar
• Ishida Y, Meisner JS, Tsujioka K, et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation. 1986;74(1):187–196. doi:10.1161/01.CIR.74.1.187
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of Systolic and Diastolic Ventricular Dysfunction in the Community. JAMA. 2003;289(2):194. doi:10.1001/jama.289.2.194
   PubMed Web of Science ®Google Scholar
• Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2001;37(4):1042–1048. doi:10.1016/S0735-1097(01)01110-X
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Gattobigio R, Sardone M, Porcellati C. Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension. Hypertension. 2005;45(3):412–418. doi:10.1161/01.HYP.0000154822.37141.f6
   PubMed Web of Science ®Google Scholar
• Tadic M, Gherbesi E, Sala C, Carugo S, Cuspidi C. Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis. J Hypertens. 2022;40(4):641–647. doi:10.1097/HJH.0000000000003079
   PubMed Web of Science ®Google Scholar
• Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol. 1986;8(6):1449–1454. doi:10.1016/S0735-1097(86)80322-9
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, Wouters S. Regression of Left Ventricular Mass by Antihypertensive Treatment. Hypertension. 2009;54(5):1084–1091. doi:10.1161/HYPERTENSIONAHA.109.136655
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou D, Yang P. Effect of amlodipine on ventricular hypertrophy in hypertension patients: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(10):10768–10778. doi:10.21037/apm-21-2455
   PubMed Web of Science ®Google Scholar
• Salcedo EE, Gockowski K, Tarazi RC. Left ventricular mass and wall thickness in hypertension. Am J Cardiol. 1979;44(5):936–940. doi:10.1016/0002-9149(79)90225-X
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458. doi:10.1016/0002-9149(86)90771-X
   PubMed Web of Science ®Google Scholar
• Lang RM, Mor-Avi V, Sugeng L, Nieman PS, Sahn DJ. Three-Dimensional Echocardiography. J Am Coll Cardiol. 2006;48(10):2053–2069. doi:10.1016/j.jacc.2006.07.047
   PubMed Web of Science ®Google Scholar
• Kühl HP, Schreckenberg M, Rulands D, et al. High-resolution transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol. 2004;43(11):2083–2090. doi:10.1016/j.jacc.2004.01.037
   PubMed Web of Science ®Google Scholar
• Tidholm A, Westling AB, Höglund K, Ljungvall I, Häggström J. Comparisons of 3-, 2-Dimensional, and M-Mode Echocardiographical Methods for Estimation of Left Chamber Volumes in Dogs with and without Acquired Heart Disease. J Vet Intern Med. 2010;24(6):1414–1420. doi:10.1111/j.1939-1676.2010.0596.x
   PubMed Web of Science ®Google Scholar
• Fries RC, Gordon SG, Saunders AB, Miller MW, Hariu CD, Schaeffer DJ. Quantitative assessment of two- and three-dimensional transthoracic and two-dimensional transesophageal echocardiography, computed tomography, and magnetic resonance imaging in normal canine hearts. J Veterinary Cardiol. 2019;21:79–92. doi:10.1016/j.jvc.2018.09.005
   PubMed Web of Science ®Google Scholar
• Li L, Shigematsu Y, Hamada M, Hiwada K. Relative Wall Thickness Is an Independent Predictor of Left Ventricular Systolic and Diastolic Dysfunctions in Essential Hypertension. Hypertension Res. 2001;24(5):493–499. doi:10.1291/hypres.24.493
   PubMed Web of Science ®Google Scholar
• Lembo M, Esposito R, Santoro C, et al. Three-dimensional echocardiographic ventricular mass/end-diastolic volume ratio in native hypertensive patients. J Hypertens. 2018;36(8):1697–1704. doi:10.1097/HJH.0000000000001717
   PubMed Web of Science ®Google Scholar
• Jung HO, Sheehan FH, Bolson EL, Waiss MP, Otto CM. Evaluation of Midwall Systolic Function in Left Ventricular Hypertrophy: a Comparison of 3-Dimensional Versus 2-Dimensional Echocardiographic Indices. J Am Society Echocardiography. 2006;19(6):802–810. doi:10.1016/j.echo.2006.01.007
   PubMed Web of Science ®Google Scholar
• Bottini P, Carr A, Prisant L, Flickinger F, Allison J, Gottdiener J. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens. 1995;8(3):221–228. doi:10.1016/0895-7061(94)00178-E
   PubMed Web of Science ®Google Scholar
• Moon JCC. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004;90(6):645–649. doi:10.1136/hrt.2003.014969
   PubMed Web of Science ®Google Scholar
• Pennell D. Clinical indications for cardiovascular magnetic resonance (CMR): consensus Panel report? Eur Heart J. 2004;25(21):1940–1965. doi:10.1016/j.ehj.2004.06.040
   PubMed Web of Science ®Google Scholar
• Grothues F, Smith GC, Moon JCC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90(1):29–34. doi:10.1016/S0002-9149(02)02381-0
   PubMed Web of Science ®Google Scholar
• Aquaro GD, Corsi E, Todiere G, et al. Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: diagnostic and Prognostic Implications. J Clin Med. 2022;11(3):651. doi:10.3390/jcm11030651
   PubMed Web of Science ®Google Scholar
• Sara JD, Toya T, Taher R, Lerman A, Gersh B, Anavekar NS. Asymptomatic Left Ventricle Systolic Dysfunction. Eur Cardiol Rev. 2020. doi:10.15420/ecr.2019.14
   PubMed Web of Science ®Google Scholar
• Morales MA, Snel GJH, van den Boomen M, et al. DeepStrain Evidence of Asymptomatic Left Ventricular Diastolic and Systolic Dysfunction in Young Adults With Cardiac Risk Factors. Front Cardiovasc Med. 2022;9. doi:10.3389/fcvm.2022.831080
   PubMed Web of Science ®Google Scholar
• Uppot RN. Technical challenges of imaging & image-guided interventions in obese patients. Br J Radiol. 2018;20170931. doi:10.1259/bjr.20170931
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zhao Y, et al. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease. Front Cardiovasc Med. 2022;9.
   Google Scholar
• Hanif W, Alex L, Su Y, et al. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. Cardiovasc. Pathol. 2017;30:27–37. doi:10.1016/j.carpath.2017.06.003
   PubMed Web of Science ®Google Scholar
• Marques MD, Weinberg R, Kapoor S, et al. Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J Cardiovasc Imaging. 2022;23(10):1407–1416. doi:10.1093/ehjci/jeac010
   PubMed Web of Science ®Google Scholar
• Vähätalo J, Holmström L, Pakanen L, et al. Temporal Trends in the Incidence and Characteristics of Sudden Cardiac Death among Subjects under 40 Years of Age in Northern Finland during 1998–2017. Cardiology. 2022;147(3):328–331. doi:10.1159/000522554
   PubMed Web of Science ®Google Scholar
• Zhuang B, Cui C, Sirajuddin A, et al. Detection of Myocardial Fibrosis and Left Ventricular Dysfunction with Cardiac MRI in a Hypertensive Swine Model. Radiol Cardiothorac Imaging. 2020;2(4):e190214. doi:10.1148/ryct.2020190214
   PubMedGoogle Scholar
• Ciulla M, Paliotti R, Hess DB, et al. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Society Echocardiography. 1997;10(6):657–664. doi:10.1016/S0894-7317(97)70028-2
   PubMed Web of Science ®Google Scholar
• Iyer NR, Le TT, Kui MSL, et al. Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: the REMODEL Study. Hypertension. 2022;79(8):1804–1813. doi:10.1161/HYPERTENSIONAHA.122.19225
   PubMed Web of Science ®Google Scholar
• Lee SE, Nguyen C, Xie Y, et al. Recent Advances in Cardiac Magnetic Resonance Imaging. Korean Circ J. 2019;49(2):146. doi:10.4070/kcj.2018.0246
   PubMed Web of Science ®Google Scholar
• Saloner D, Liu J, Haraldsson H. MR Physics in Practice. Magn Reson Imaging Clin N Am. 2015;23(1):1–6. doi:10.1016/j.mric.2014.08.004
   PubMed Web of Science ®Google Scholar
• Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovascular Magnetic Resonance. 2013;15(1):91. doi:10.1186/1532-429X-15-91
   PubMedGoogle Scholar